340 related articles for article (PubMed ID: 35658861)
21. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
Petrick JL; Kelly SP; Liao LM; Freedman ND; Graubard BI; Cook MB
Br J Cancer; 2017 Mar; 116(7):951-959. PubMed ID: 28196067
[TBL] [Abstract][Full Text] [Related]
22. Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK.
Iyen B; Weng S; Vinogradova Y; Akyea RK; Qureshi N; Kai J
BMC Public Health; 2021 Apr; 21(1):576. PubMed ID: 33853578
[TBL] [Abstract][Full Text] [Related]
23. DNA methylome analysis identifies BMI-related epigenetic changes associated with non-small cell lung cancer susceptibility.
Li G; Meng H; Bai Y; Wei W; Feng Y; Li M; Li H; He M; Zhang X; Wei S; Li Y; Guo H
Cancer Med; 2021 Jun; 10(11):3770-3781. PubMed ID: 33939316
[TBL] [Abstract][Full Text] [Related]
24. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
[TBL] [Abstract][Full Text] [Related]
25. Body mass index and incidence of lung cancer in the HUNT study: using observational and Mendelian randomization approaches.
Jiang L; Sun YQ; Brumpton BM; Langhammer A; Chen Y; Mai XM
BMC Cancer; 2022 Nov; 22(1):1152. PubMed ID: 36348315
[TBL] [Abstract][Full Text] [Related]
26. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
Hyun SH; Lee KH; Choi JY; Kim BT; Kim J; Zo JI; Kim H; Kwon OJ; Ahn HK
PLoS One; 2015; 10(12):e0145020. PubMed ID: 26684001
[TBL] [Abstract][Full Text] [Related]
27. Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk.
Arjani S; Saint-Maurice PF; Julián-Serrano S; Eibl G; Stolzenberg-Solomon R
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36255251
[TBL] [Abstract][Full Text] [Related]
28. Body mass index and glioma risk: A prospective multicenter study.
Shao C; Tang H; Wang X; He J; Wang P; Wu N
Front Endocrinol (Lausanne); 2022; 13():933921. PubMed ID: 36105407
[TBL] [Abstract][Full Text] [Related]
29. Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hoyt M; Song Y; Gao S; O'Palka J; Zhang J
Obesity (Silver Spring); 2022 Nov; 30(11):2275-2285. PubMed ID: 36156459
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
[TBL] [Abstract][Full Text] [Related]
31. Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial.
Luo L; Liu Y; Wang Z; Yan Y; Xie C; Chi J; Yang Y; Li J; Xu R
Ann Transl Med; 2020 Jul; 8(13):815. PubMed ID: 32793660
[TBL] [Abstract][Full Text] [Related]
32. Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.
Wang C; Guo M; Zhang N; Wang G
World J Surg Oncol; 2018 May; 16(1):90. PubMed ID: 29751759
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer.
Chu H; Xin J; Yuan Q; Wu Y; Du M; Zheng R; Liu H; Wu S; Zhang Z; Wang M
Environ Int; 2021 Feb; 147():106309. PubMed ID: 33338681
[TBL] [Abstract][Full Text] [Related]
34. Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study.
Fukumoto K; Mori S; Shintani Y; Okami J; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Asamura H; Chida M; Date H; Endo S; Nagayasu T; Nakanishi R; Miyaoka E; Okumura M; Yoshino I;
Lung Cancer; 2020 Nov; 149():120-129. PubMed ID: 33010640
[TBL] [Abstract][Full Text] [Related]
35. Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.
Lavalette C; Cordina Duverger E; Artaud F; Rébillard X; Lamy PJ; Trétarre B; Cénée S; Menegaux F
Cancer Med; 2020 Sep; 9(17):6421-6429. PubMed ID: 32639678
[TBL] [Abstract][Full Text] [Related]
36. A two-stage genome-wide association study identified four potential early-onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population.
Fan J; Hong T; Zhao X; Liang S; Zhu M; Jiang Y; Jin G; Hu Z; Ma H; Dai J; Shen H
Mol Carcinog; 2023 Sep; 62(9):1263-1270. PubMed ID: 37232355
[TBL] [Abstract][Full Text] [Related]
37. Trajectories of body mass index among Canadian seniors and associated mortality risk.
Wang M; Yi Y; Roebothan B; Colbourne J; Maddalena V; Sun G; Wang PP
BMC Public Health; 2017 Dec; 17(1):929. PubMed ID: 29202810
[TBL] [Abstract][Full Text] [Related]
38. Body mass index trajectories, weight gain and risks of liver and biliary tract cancers.
Yang W; Zeng X; Petrick JL; Danford CJ; Florio AA; Lu B; Nan H; Ma J; Wang L; Zeng H; Sudenga SL; Campbell PT; Giovannucci E; McGlynn KA; Zhang X
JNCI Cancer Spectr; 2022 Aug; 6(4):. PubMed ID: 35960613
[TBL] [Abstract][Full Text] [Related]
39. Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
Tang D; Zhao YC; Liu H; Luo S; Clarke JM; Glass C; Su L; Shen S; Christiani DC; Gao W; Wei Q
Int J Cancer; 2020 Sep; 147(6):1559-1570. PubMed ID: 32072637
[TBL] [Abstract][Full Text] [Related]
40. Adult lifetime body mass index trajectories and endometrial cancer risk.
Dalmartello M; Vermunt J; Negri E; Levi F; La Vecchia C
BJOG; 2022 Aug; 129(9):1521-1529. PubMed ID: 34962692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
